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The problem of the molecular mechanism for terminatSummary ing G protein activation has been particularly perplexing.
The intrinsic GTPase activity of G␣ t hydrolyzes bound The rod outer segment phototransduction GAP (GTPase-GTP and returns the G protein to the inactive state on accelerating protein) has been identified as RGS9, a a time scale of tens of seconds (Angleson and Wensel, member of the RGS family of G␣ GAPs. RGS9 mRNA 1993) and is thus too slow to account for observed expression is specific for photoreceptor cells, and phototransduction inactivation kinetics. It was proposed RGS9 protein colocalizes with other phototransduca decade ago that the resolution of this discrepancy lies tion components to photoreceptor outer segment in the action of one or more accessory factors that act membranes. The RGS domain of RGS9 accelerates on G␣ t to accelerate GTP hydrolysis, and, indeed, photo-GTP hydrolysis by the visual G protein transducin (G␣ t ), transduction was the first G protein cascade in which and this acceleration is enhanced by the ␥ subunit of the action of a GTPase-accelerating protein (GAP) was the phototransduction effector cGMP phosphodiesdemonstrated (Dratz et al., 1987; Arshavsky et al., 1989) .
terase (PDE␥). These unique properties of RGS9 match
However, the identification of the protein or proteins those of the rod outer segment GAP and implicate responsible has remained an elusive goal (Arshavsky it as a key element in the recovery phase of visual and Bownds, 1992; Angleson and Wensel, 1993, 1994 ; transduction. Antonny et al., 1993; Yamazaki et al., 1993; Pages et al., 1993; Otto-Bruc et al., 1994; Chen et al., 1996; Faurobert Introduction and Hurley, 1997; Nekrasova et al., 1997) . Despite initial reports that G␣ t did not require an addi-A challenging problem in phototransduction has been tional protein for subsecond GTP hydrolysis (Vuong and to understand the molecular basis for the temporal reso- Chabre, 1990 Chabre, , 1991 or that the PDE ␥ subunit was the lution of vision. Psychophysical and electrophysiologi-GAP for G␣ t (Arshavsky and Bownds, 1992) , there is now cal experiments have revealed that the sequence of light considerable evidence that a G␣t GAP distinct from PDE activation and recovery can occur in less than 1 s in subunits is present in rod outer segment (ROS) memmammalian rods and is even faster in cones (Hecht and branes (Angleson and Wensel, 1993, 1994; Antonny et Verrijp, 1933; Baylor et al., 1984; Kraft, 1988; Schnapf al., 1993; Otto-Bruc et al., 1994) . Moreover, it is wellet al ., 1990) . The molecular properties of the identified established that PDE ␥ forms a tight complex with G␣t mediators of the phototransduction cascade are wellwithout accelerating GTP hydrolysis (Angleson and suited to achieving activation on this time scale. Upon Wensel, 1993 Wensel, , 1994 Antonny et al., 1993; Pages et al., light activation, the photon receptor rhodopsin catalyzes 1993; Yamazaki et al., 1993; Arshavsky et al., 1994 ; Ottorapid release of GDP and uptake of GTP by the G protein Bruc et al., 1994; Nekrasova et al., 1997) but can enhance transducin (Gt), leading, on a millisecond time scale, to GTP hydrolysis in the presence of an ROS membrane activation of transducin's effector, cGMP phosphodiesprotein (Angleson and Wensel, 1994; Arshavsky et al., terase (PDE) . PDE rapidly reduces cytoplasmic [cGMP], 1994; Nekrasova et al., 1997) . causing closure of cation channels cooperatively gated Identification of members of the RGS protein family by cGMP. A model capable of remarkably accurate pre- (De Vries et al., 1995; Druey et al., 1996 ; Koelle and diction of the activation phase of the light response Horvitz, 1996) as GAPs for G␣ subunits (Berman et al., can be calculated using only parameters derived from 1996; Watson et al., 1996) raised the possibility that careful measurements or reasonable estimates for this the ROS GAP might be an RGS protein. So far, few limited set of molecules and from the well-supported biochemical studies have been carried out on endogeassumption of a constant rate of cGMP synthesis during nous RGS proteins in their native environments. Howthis early phase (Lamb and Pugh, 1992; Pugh and Lamb, ever, cloned RGS cDNA has been used to express 1993). several mammalian RGS proteins or their RGS domains In contrast, the molecular basis for rapid termination in Escherichia coli, allowing them to be assayed for of the light response is much less well-understood. Mul-GAP activity toward purified G proteins. Although all tiple biochemical events appear to be involved, includthe expressed proteins have been soluble, those RGS ing receptor inactivation and stimulation of cGMP synproteins whose localization in cells has been studied thesis (both processes are likely to be regulated by have proven to be membrane-associated (De Vries et al., 1996; Dohlman et al., 1996) , as is the ROS GAP ‡ To whom correspondence should be addressed. § These authors contributed equally to this work. (Angleson and Wensel, 1993, 1994) . Interestingly, all RGS proteins studied to date act as fairly nonspecific accelerators of GTP hydrolysis for all members of the G i subfamily of G␣ proteins (Berman et al., 1996; Chen et al., 1996; Hunt et al., 1996; Watson et al., 1996) and also for G␣ q (Hepler et al., 1997) . G␣ t , a member of the G i subfamily, has been shown to serve as a substrate for all RGS proteins tested so far, including RGS1, RGS4, and GAIP (Watson et al., 1996) , RGS16 (also referred to as RGS-r; Chen et al., 1996) , and RET-RGS1 (Faurobert and Hurley, 1997) . This lack of specificity has raised a number of interesting questions about why so many RGS proteins with such similar biochemical properties exist and how specificity for various G protein pathways might be achieved by superficially promiscuous members of the RGS protein family. Another puzzle concerning RGS interactions with G␣t has been the observation that in contrast to PDE ␥ enhancement of the activity of endogenous ROS GAP, the G␣ t -GAP activity of RGS4, GAIP, RGS16, and A28-RGS14 is inhibited by PDE ␥ (Natochin et al., 1997; Nekrasova et al., 1997; , leading to the suggestion that the PDE ␥ -dependent ROS GAP may not be an RGS protein (Nekrasova et al., 1997) .
We report here the identification of the ROS GAP protein as RGS9. Localization and activity characteristics of RGS9 are consistent with the highly concentrated, specialized, and spatially restricted nature of the phototransduction cascade and its components, as well as with all of the previously established biochemical properties of the ROS GAP, including enhancement by PDE ␥ . RGS9 is now a mammalian RGS protein identified with anisms for achieving specificity in G protein regulation 3 g retina, 10 g brain, 6 g heart, 10 g lung, 10 g kidney, 10
by RGS proteins. RGS3, RGS4, RGS6, RGS16, and RGS11. These amplification products were then used as probes to isolate cDNA clones for bovine RGS9, RGS4, RGS16, and is much higher in retina than in other tissues, including RGS7, as well as for murine RGS9, RGS7, RGS6, and the brain, the one other tissue where RGS9 RNA has RGS11. RGS16 is the name we are tentatively assigning been detected (Koelle and Horvitz, 1996 ; C. W. C. et al., a bovine protein whose sequence is more than 80% unpublished data). identical to murine and human proteins variously termed RGS-r (Chen et al., 1996; Natochin et al., 1997) , A28-Photoreceptor-Specific Expression of RGS9 RGS14 (Buckbinder et al., 1997) , and RGS16 (Chen et Analysis by in situ hybridization localized retinal expresal., 1997).
sion to the outer nuclear layer and inner segment layer, indicating a high degree of specificity for photoreceptor cells ( Figures 1C-1F ). This same pattern was observed Retina-Specific Expression of RGS9 When probes generated from these clones were used with three different probes, using either digoxigenin (Figure 1C) or 35 S labeling ( Figure 1E ) for probe detection. to examine mRNA expression by Northern blotting and in situ hybridization, only RGS9 probes revealed a strong
With the digoxigenin-labeled probes, a highly concentrated signal in the myoid region of the rod inner segpattern of retinal and photoreceptor specificity ( Figure  1 ). In Northern blots, RGS9 message was easily detectments was observed, consistent with results obtained for rhodopsin and G␣ t . The labeling was sufficiently able with 3 g of total retinal RNA, while no signal could be detected with 10 g of RNA from other tissues (Figure dense to assure expression in rods but also to make it difficult to determine whether cones were labeled. In 1A). These results indicate that RGS9 mRNA expression addition to retinal expression, some RGS9 mRNA is also Within the RGS-N domain, there is an ‫08ف‬ residue sequence that meets the criteria for a proposed DEP dofound in rodent brain (Koelle and Horvitz, 1996) , where it displays a highly restricted striatal expression pattern main found within many signaling pathway proteins (Ponting and Bork, 1996) , although the functional sig-(Gold et al., 1997; C. W. C., unpublished data).
nificance of this domain is currently unknown. A unique feature of RGS9 among known RGS proteins is a 52 RGS9 Primary Structure Defines an RGS Subfamily amino acid C-terminal tail. The sequence of the bovine RGS9 open reading frame predicted a 484 amino acid protein (Figure 2A ) of 56.7 kDa calculated molecular mass. The predicted mouse Localization of RGS9 Protein to Rod Outer Segments protein is 91.5% identical. Bovine ( Figure 2A ) and mouse RGS7 clones predict 469 amino acid proteins, 99% idenWe generated polyclonal antibodies that recognized recombinant RGS9 and used them to determine whether tical to one another and to a partial human sequence (Koelle and Horvitz, 1996) . RGS9 and RGS7 share con-RGS9 protein is present in photoreceptor outer segments. Western blots with anti-RGS9 immune serum but siderable sequence identity outside the RGS domain, especially over a domain of ‫091ف‬ amino acids near the not preimmune serum revealed an immunoreactive band of the same electrophoretic mobility as full-length re-N terminus, where identity (42%) is nearly as high as in the RGS domain (49%). This conserved RGS-N domain combinant His-RGS9 in purified ROS preparations, with no other immunoreactive bands detected ( Figure 3A) . is shared by EGL-10, the Caenorhabditis elegans synapse-specific RGS protein (Koelle and Horvitz, 1996) , To verify that the immunoreactive band in ROS was RGS9, we performed partial V8 protease digestion mapand by partial sequences from RGS6 and RGS11 (W. H., unpublished data). Comparison of RGS domain seping. Digestion patterns for recombinant full-length His-RGS9 and the immunoreactive band in ROS were identiquences also suggests that RGS9, RGS7, RGS6, RGS11, and EGL-10 belong to a subfamily of RGS proteins.
cal ( Figure 3B ), verifying the presence of RGS9 in ROS.
The similarity in primary structure of RGS9 and other subfamily members (RGS6, RGS7, RGS11) raises the possibility of confusion of these with RGS9 in immunoblots. We tested our RGS9 antibodies for cross-reactivity with recombinant RGS7 and found that more than 100-fold higher levels of RGS7 were needed to obtain signals comparable to those obtained with RGS9. Immunoblots with RGS7-specific antibodies revealed that its levels in ROS are undetectable (i.e., at least 100-fold lower than RGS9 levels), thus ruling out detectable cross-reactivity with RGS7 as a source of confusion in Figure 3 (W. H., unpublished data). As the other subfamily members (RGS6 and RGS11) show even less retinal expression at the mRNA level than RGS7, and the other retinal RGS proteins differ greatly in molecular weight from RGS9, it is extremely unlikely that the immunoblotting results shown in Figure 3 could represent crossreactivity with another retinal RGS protein.
To determine whether RGS9 is an endogenous ROS protein or is simply a contaminant originating from inner segments or other cells in the retina, we used the RGS9 antibodies to assay for RGS9 protein at all stages of a sucrose density purification of ROS from bovine retinas. We found that RGS9 protein copurified with rhodopsin ( Figure 3C ), the major component of ROS, and was not detectable in any samples enriched in non-ROS components. Thus, RGS9 is predominantly a photoreceptor outer segment protein.
We also used immunoblots to explore the solubility of endogenous RGS9 in ROS. A buffer of moderate ionic C. W. C., unpublished data), the nonionic detergent octyl (C) RGS9 colocalization with rhodopsin in ROS purification from glucoside (OG) did solubilize RGS9. Approximately half bovine retinas. ROS were purified from bovine retinas by a discontinof the RGS9 was solubilized at 30 mM OG, with maximal uous sucrose density gradient (Papermaster and Dreyer, 1974) , and solubilization at 40 mM (in buffer C). This is the same fractions were analyzed by change in rhodopsin absorbance at 500 nm after bleach (closed circles). Fractions were also analyzed by concentration at which maximal soluble GAP activity is immunoblot using anti-RGS9c rabbit polyclonal serum (inset). of RGS9 expressed so far have been insoluble, apparently sequestered within inclusion bodies in E. coli. While full-length RGS9 was completely insoluble after Estimates of the ratio of RGS9 to rhodopsin in three purification and slow removal of denaturant (see Experiseparate ROS preparations were made by densitometric mental Procedures), two forms (His-RGS9c, His-RGS9d) comparison of the immunoblot signals obtained with retained sufficient solubility for their GAP activity to be varying amounts of recombinant RGS9 to those obtested, with His-RGS9d being the more soluble of the tained on the same blot from ROS containing an amount two. Both accelerated GTP hydrolysis by G␣t. Results of rhodopsin determined by spectrophotometry ( Figure  with His-RGS9d, a recombinant fragment containing the 3D). The results gave an estimate of 1 mole of RGS9 RGS core domain and an N-terminal His 6 tag, are shown per 1640 (Ϯ 619) mole of rhodopsin, or about 1 molecule in Figure 4 for a single-turnover GTPase assay (Angleson of RGS9 for every 6.6 molecules of holo-PDE (PDE␣␤␥␥) and Wensel, 1993 Wensel, , 1994 that is sensitive to the hydrolyin ROS. Because of the tight membrane association of sis of bound GTP rather than the kinetics of nucleotide RGS9 (see below), it seems unlikely that there is much loss during ROS purification.
exchange. In the absence of His-RGS9d, GTP hydrolysis that PDE ␥ inhibits GAP activity of other nonphotoreceptor-specific RGS proteins (RGS4, GAIP, RGS16), while PDE ␥ enhances GAP activity of the endogenous ROS GAP (Arshavsky and Bownds, 1992; Angleson and Wensel, 1994) . At PDE ␥ concentrations in the range of 33-333 nM, significant enhancement of GTPase acceleration was observed (Figure 4 , inset), with a maximal effect of about 3-fold (333 nM PDE ␥ ; k inact ϭ 0.24 s
Ϫ1
). By itself, i.e., without added RGS9, PDE ␥ at concentrations up to 3.3 M did not significantly accelerate transducin GTPase, as reported previously (Angleson and Wensel, 1993, 1994; Antonny et al., 1993) . At higher HisRGS9d concentrations (e.g., 2-3 M) PDE ␥ also enhanced GAP activity, but the fold activation was less While PDE ␥ enhancement of GTPase acceleration by His-RGS9d is somewhat less than that observed for the endogenous ROS GAP, the recombinant protein is was slow (kinact ϭ 0.022 s
), whereas addition of Hismissing more than half of the mass of RGS9, and it is RGS9d resulted in dramatic acceleration of GTP hypossible that restoration of the missing N-and C-termidrolysis by transducin. At 8 M, His-RGS9d increased nal domains and reconstitution of proper membrane the percent of GTP hydrolyzed in 5 s from the basal value association could increase the enhancement. of 19.8% Ϯ 2.1%, corresponding to a kinact of 0.022 s
, to
This observation of enhancement is in sharp contrast 99.5% Ϯ 1.8%, corresponding to a nominal kinact of 1.04 to the potent inhibition by PDE ␥ of RGS16 (Natochin et s Ϫ1 . Because the value of k inact , calculated as described in al. , GAIP, and RGS4 (NekraExperimental Procedures, becomes much less accurate sova et al., 1997). Interestingly, only partial inhibition when more than 90% of the GTP is hydrolyzed, these was observed with GAIP and RGS4 at saturating PDE ␥ , results allow us to estimate only a lower limit for the indicating that an RGS domain and PDE ␥ can bind transmaximal GTPase acceleration by His-RGS9d: k inact ϭ ducin simultaneously, as implied by the enhancement 0.71 s
, corresponding to the lower extreme of the error of GAP activity we observe and by direct binding studies bar for the 8 M point in Figure 4 . However, it seems with RGS16 (Natochin et al., 1997) . likely that maximal GTPase acceleration is even greater than that suggested by the kinact calculated for the average value of GTP hydrolyzed at 8 M His-RGS9d; i.e.,
Other Retinal RGS Proteins
In addition to RGS9, several other RGS cDNAs have kinact Ͼ 1.04 s
Ϫ1
, implying acceleration greater than 47-fold. This result does not necessarily represent the maxibeen isolated from retinal cDNA libraries. These include RGS4, RGS3, RGS7, RGS6, RGS11 (this work), RGS16 mal GTPase acceleration attainable by RGS9, even at 23ЊC, as determination of that value will require solubili-(this work; Chen et al., 1996; Natochin et al., 1997) , and RET-RGS1 (Faurobert and Hurley, 1997) . We explored zation and purification in active form of full-length recombinant or endogenous RGS9 as well as the use of the expression patterns of RGS4, RGS7, RGS6, RGS11, and RGS16 (data not shown) and found none of them assays with greater temporal resolution. The relatively high concentrations of His-RGS9d required for GTPase to be expressed in the retina at levels comparable to those of RGS9. All were expressed in other tissues at acceleration raise the interesting possibility that G t inactivation may be limited by intracellular RGS9 concentrahigher levels than in the retina, except for RGS16. However, photoreceptor expression of RGS16 RNA was untions. detectable using the same in situ hybridization conditions as used for Figures 1C-1F , and when the Northern Enhancement of RGS9 GAP Activity by the Effector Subunit PDE␥ blot used for Figures 1A and 1B was probed for RGS16, its RNA could be readily detected in the liver as well as As explained above, kinact values become less accurate using our standard GTPase assay when almost all of the retina. In other work, RGS16 was reported to be specific for the liver and pituitary , the GTP is hydrolyzed before quenching, as occurs at high His-RGS9d concentrations. Therefore, to see if and human A28-RGS14, which has been reported to be the human ortholog of RGS16 (Natochin et al., 1997) , PDE ␥ could enhance GAP activity of RGS9, we tested a concentration of His-RGS9d that gave intermediate shows a widespread pattern of expression in multiple human tissues (Buckbinder et al., 1997) . This expression GTPase acceleration (1 M; k inact ϭ 0.08 s
) for the effect of adding PDE ␥ . Previous studies (Natochin et al., 1997;  pattern and the inhibitory effects of PDE ␥ on RGS16 GAP activity render RGS16/RGS-r an unlikely candidate Nekrasova et al., 1997; Wieland et al., 1997) have found for the ROS GAP. Likewise, RET-RGS1 (Faurobert and temperature is increased from 23ЊC to 37ЊC (Arshavsky et al., 1987; Ting and Ho, 1991; Angleson and Wensel, Hurley, 1997) does not show the photoreceptor-specific pattern of expression in the retina expected for a major 1993). Therefore, GTP hydrolysis in mammalian retina is likely to be at least twice as fast as the maximum rate phototransduction component. No evidence has been reported for the presence of any of these proteins other constant we have observed with His-RGS9d, corresponding to a time constant of about 0.5 s or less. than RGS9 in ROS. It is likely that these multiple RGS proteins expressed at low levels in the retina and elsewhere play important roles in other G protein pathways RGS9 and GTPase Acceleration in Cones whose components are less concentrated and specialWhile the properties of RGS9 match well those of the ized than those of phototransduction; alternatively, if endogenous GAP of ROS, it or a closely related RGS they are present in ROS, they may supplement the role protein is very likely to be present at high levels in cone of RGS9.
outer segments. Preliminary immunocytochemical results with mouse antisera raised against RGS9 reveal that both rod and cone outer segments are stained, but RGS9 as the ROS Transducin GAP the signal in cones is stronger (K. Palczewski, personal Unlike any other RGS proteins examined so far, RGS9 communication). The response kinetics of cones are displays all the hallmarks of an endogenous ROS GAP much faster than those of rods, and GTPase accelerafor transducin: (1) its mRNA expression is the most spetion by RGS9 may be the answer to the long-standing cific for the retina; (2) within the retina, the expression question of how physiological recovery on time scales is restricted to photoreceptors, a pattern it shares with of tens of milliseconds (Hecht and Verrijp, 1933 ; Schnapf other transduction components, such as transducin ␣ et al., 1990) can be mediated by G proteins with hydrolyand ␥ subunits, PDE subunits, rhodopsin, and cone visis kinetics on the order of tens of seconds. sual pigments, and the cGMP-gated channel subunits; (3) RGS9 protein is predominantly localized in outer seg- In amphibians, this value has been established as apperformed as described (Albrecht et al., 1997) . High-stringency proximately 2 s over a wide range of light intensities washes were performed at 66ЊC. Alternatively, hybridization was (Nikonov et al., 1998) , so even within the limits of our carried out with digoxygenin-labeled probes as recommended by current assays, it seems likely that RGS9-accelerated the reagent manufacturer (Boehringer Mannheim), with visualization GTP hydrolysis would be kinetically competent to play by anti-digoxigenin alkaline phosphatase conjugate and NBT/BCIP. The digoxigenin-labeled RGS9 probes were generated using a 698 this role. Electroretinographic studies in mice suggest bp 3Ј-untranslated region, beginning at the stop codon, from the it is an order of magnitude faster ‫2.0ف(‬ s; Lyubarsky RGS9 cDNA, subcloned into pCR-Script Amp SK(ϩ).
and , so it will be necessary to determine if at physiological concentrations of RGS9, PDE subunits, (Angleson and Wensel, 1994) Angleson, J.K., and Wensel, T.G. (1993) . A GTPase-accelerating for both enhancement of ROS GAP activity and inhibition of trypsinfactor for transducin, distinct from its effector cGMP phosphodiesactivated PDE. His-PDE ␥ concentration was calculated from a functerase, in rod outer segment membranes. Neuron 11, 939-949. tional protein assay as described (Angleson and Wensel, 1993) .
Angleson, J.K., and Wensel, T.G. (1994) . Enhancement of rod outer segment GTPase accelerating protein activity by the inhibitory subunit of cGMP phosphodiesterase. J. Biol. Chem. 269, 16290-16296.
Antibodies and Immunoblot Analysis
Antonny, B., Otto-Bruc, A., Chabre, M., and Vuong, T.M. (1993) . GTP Rabbits were injected with purified His-RGS9c at Bethyl Laborahydrolysis by purified alpha-subunit of transducin and its complex tories using a standard immunization protocol. Preimmune and with the cyclic GMP phosphodiesterase inhibitor. Biochemistry 32, immune sera were tested for immunoreactivity to His-RGS9c by 8646-8653. Western blot analysis on nitrocellulose membranes by standard techniques (Harlow and Lane, 1988) . Blots were incubated overnight Arshavsky, V.Y., and Bownds, M.D. (1992) . Regulation of deactivawith a 1/1000 dilution of His-RGS9c rabbit antiserum in 5% nonfat tion of photoreceptor G protein by its target enzyme and cGMP. dry milk/TBS, followed by incubation for 45 min with 1/10,000 diluNature 357, 416-417. tion of anti-rabbit peroxidase antibodies (Amersham ECL kit). WestArshavsky, V.Y., Antoch, M.P., and Philippov, P.P. (1987) . On the ern blots were developed using the ECL kit (Amersham) and exposed role of transducin GTPase in the quenching of a phosphodiesterase to Kodak Biomax MR film. Partial V8 protease digestion of proteins cascade of vision. FEBS Lett. 224, 19-22. excised from gel bands was carried out as described (Harlow and Arshavsky, V.Y., Antoch, M.P., Lukjanov, K.A., and Philippov, P.P. Lane, 1988 Lane, ). (1989 . Transducin GTPase provides for rapid quenching of the cGMP cascade in rod outer segments. FEBS Lett. 250, [353] [354] [355] [356] 
